Patent · US Active

Mesocellular oxide foams as hemostatic compositions and methods of use

US8603543B2 · kind B2 · utility

2Cited by
5References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 2, 2012
Grant dateDec 10, 2013
Priority date
Expiry dateMay 12, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2400/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to hemostatic compositions comprising a mesocellular oxide foam and, optionally, a biologically active agent such as a procoagulant, as well as devices and methods of use to promote blood clotting.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.